We narrowed to 294 results for: cha

1. pAAV-CAG-DIO-NLS-mRuby3-IRES-eGtACR1-ST (AAV9)

   Viral Prep

   #109048-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CAG-DIO-NLS-mRuby3-IRES-eGtACR1-ST (#109048). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-NLS-mRuby3-IRES-eGtACR1-ST plasmid DNA. Cre-dependent expression of the anion channelrhodopsin GtACR1 fused to ER export signal and targeted to the neuronal soma and proximal dendrites, translated from an internal ribosomal entry site (IRES) following mRuby3 expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Hillel Adesnik

   Article

   Mardinly et al Nat Neurosci. 2018 Apr 30. pii: 10.1038/

   Promoter

   CAG

   Tags

   mRuby3

   Available Since

   Feb. 5, 2024

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (AAV5)

   Viral Prep

   #55645-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (#55645). In addition to the viral particles, you will also receive purified pAAV-hSyn Con/Fon hChR2(H134R)-EYFP plasmid DNA. Synapsin-driven, Cre-dependent and Flp-dependent channelrhodopsin-EYFP expression for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

   Promoter

   Syn

   Tags

   EYFP (Cre- and Flp-dependent)

   Available Since

   Dec. 2, 2019

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (AAV5)

   Viral Prep

   #62723-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (#62723). In addition to the viral particles, you will also receive purified pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] plasmid DNA. Cre-dependent ChrimsonR-tdTomato under the control of the Synapsin promoter. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   Syn

   Tags

   tdTomato (Cre-dependent)

   Available Since

   July 21, 2017

   Availability

   Academic Institutions and Nonprofits only

4. AAV-CAG-FLPX-rc [ChrimsonR-tdTomato] (AAV8)

   Viral Prep

   #130909-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from AAV-CAG-FLPX-rc [ChrimsonR-tdTomato] (#130909). In addition to the viral particles, you will also receive purified AAV-CAG-FLPX-rc [ChrimsonR-tdTomato] plasmid DNA. CAG-driven, Flp-dependent expression of ChrimsonR-tdTomato. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   CAG

   Tags

   tdTomato (Flp-dependent)

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (AAV9)

   Viral Prep

   #55645-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (#55645). In addition to the viral particles, you will also receive purified pAAV-hSyn Con/Fon hChR2(H134R)-EYFP plasmid DNA. Synapsin-driven, Cre-dependent and Flp-dependent channelrhodopsin-EYFP expression for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

   Promoter

   Syn

   Tags

   EYFP (Cre- and Flp-dependent)

   Available Since

   June 8, 2020

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (AAV1)

   Viral Prep

   #62723-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] (#62723). In addition to the viral particles, you will also receive purified pAAV-Syn-FLEX-rc[ChrimsonR-tdTomato] plasmid DNA. Cre-dependent expression of ChrimsonR-tdTomato under the control of the Synapsin promoter. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   Syn

   Tags

   tdTomato (Cre-dependent)

   Available Since

   Sept. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-hsyn-ASAP5-Kv2.1-WPRE (AAV1)

   Viral Prep

   #225707-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hsyn-ASAP5-Kv2.1-WPRE (#225707). In addition to the viral particles, you will also receive purified pAAV-hsyn-ASAP5-Kv2.1-WPRE plasmid DNA. Syn-driven, soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Michael Lin

   Article

   Hao et al Neuron. 2024 Sep 17:S0896-6273(24)00643-

   Promoter

   Syn

   Tags

   None

   Available Since

   Aug. 6, 2025

   Availability

   Academic Institutions and Nonprofits only

8. AAV-Syn-FLPX-rc [ChrimsonR-tdTomato] (AAV8)

   Viral Prep

   #128589-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from AAV-Syn-FLPX-rc [ChrimsonR-tdTomato] (#128589). In addition to the viral particles, you will also receive purified AAV-Syn-FLPX-rc [ChrimsonR-tdTomato] plasmid DNA. Syn-driven, Flp-dependent ChrimsonR-tdTomato expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   Syn

   Tags

   tdTomato

   Available Since

   Feb. 14, 2022

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (AAV8)

   Viral Prep

   #55645-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (#55645). In addition to the viral particles, you will also receive purified pAAV-hSyn Con/Fon hChR2(H134R)-EYFP plasmid DNA. Synapsin-driven, Cre-dependent and Flp-dependent Channelrhodopsin-EYFP expression for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

   Promoter

   Syn

   Tags

   EYFP (Cre- and Flp-dependent)

   Available Since

   Feb. 23, 2018

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-Syn-Chronos-GFP (AAV Retrograde)

    Viral Prep

    #59170-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-Syn-Chronos-GFP (#59170). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-GFP plasmid DNA. Chronos-GFP under the control of the Synapsin promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    Syn

    Tags

    GFP

    Available Since

    Oct. 3, 2017

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-Syn-Chronos-tdTomato (AAV8)

    Viral Prep

    #62726-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Syn-Chronos-tdTomato (#62726). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-tdTomato plasmid DNA. Syn-driven Chronos-tdTomato expression for optogenetic neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    Syn

    Tags

    tdTomato

    Available Since

    Feb. 7, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-EF1α1.1-ChrimsonR-GFP (AAV2)

    Viral Prep

    #122063-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-EF1α1.1-ChrimsonR-GFP (#122063). In addition to the viral particles, you will also receive purified pAAV-EF1α1.1-ChrimsonR-GFP plasmid DNA. EF1a-driven expression of ChrimsonR-GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    EF1a（1.1kb short version)

    Tags

    GFP

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (AAV9)

    Viral Prep

    #225708-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (#225708). In addition to the viral particles, you will also receive purified pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Michael Lin

    Article

    Hao et al Neuron. 2024 Sep 17:S0896-6273(24)00643-

    Promoter

    EF1α

    Tags

    None

    Available Since

    Sept. 22, 2025

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (AAV Retrograde)

    Viral Prep

    #55645-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (#55645). In addition to the viral particles, you will also receive purified pAAV-hSyn Con/Fon hChR2(H134R)-EYFP plasmid DNA. Synapsin-driven, Cre-dependent and Flp-dependent Channelrhodopsin-EYFP expression for optogenetic activation. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    Syn

    Tags

    EYFP (Cre- and Flp-dependent)

    Available Since

    Dec. 5, 2017

    Availability

    Academic Institutions and Nonprofits only